Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Ernest Mario, Pappas partner who steered Alza into J&J deal, passes away

“His counsel and legacy will always remain with us,” says Pappas team

October 29, 2024 11:12 PM UTC

Pappas Ventures announced the passing of Senior Venture Partner Ernest Mario, a longtime biopharma executive who led and invested in biopharmas across several decades. He was 86.

Mario may have been best known for guiding delivery company Alza Corp. through its $12.3 billion acquisition by Johnson & Johnson (NYSE:JNJ) in 2001, a deal that was among the largest in pharma history when it took place. Before joining Alza in 1993, he had been CEO of Glaxo plc, now GSK plc (LSE:GSK; NYSE:GSK), for nearly four years...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Pappas Ventures